News

FECCIA

FECCIA response to the Commission’s proposal for a revision of the European Works Council Directive 2009/38/EC

Successful kick-off of the #ChemSkills blueprint!

Congratulations and a big thank you to Anni, Emma, Chiara and Eleonora for a successful kick-off of the #ChemSkills blueprint!

Other

BASF to Acquire Shares in Alsachimie

BASF and DOMO Chemicals have signed an agreement giving BASF the right to acquire DOMO Chemicals' 49% stake in the Alsachimie joint venture, in which BASF currently holds 51%.

Q1 2025 Chemical Industry: Diverging Trends

The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.

Asahi Kasei to Exit MMA and PMMA Businesses

The Japanese chemical group Asahi Kasei has announced that it will end the production of methyl methacrylate (MMA) monomer and other chemicals in Kawasaki City, restructure the site, and focus on its Energy & Infrastructure division.

Henkel and Sasol Partner to Create Low-Carbon Adhesive Solutions

The collaboration is based on Sasol's advanced wax technology to reduce CO2 emissions along Henkel's adhesive value chain.

Standing Strong for Europe's Chemical Industry

From Listening to Action

Rising tariffs and regulatory changes challenge the European chemical industry, highlighting the need for resilient regional supply networks and strategic collaboration among CEFIC members.

How the industry can navigate through a particularly challenging environment

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles. On the other hand, expiring patents, increasing competition, cost pressure, falling productivity in R&D and the uncertainties of the US government are putting the viability of the business model to the test.

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Roche Invests $50 Billion in Pharmaceuticals & Diagnostics

Roche recently announced that it will invest $50 billion (€43.8 billion) into the United States in the next five years.

Merck to Acquire US Biopharma Company SpringWorks Therapeutics

Merck KGaA and SpringWorks Therapeutics, Inc., a Stamford, Connecticut-based commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced the companies have entered into a definitive agreement for Merck to acquire SpringWorks.